iShares U.S. Healthcare ETF

The only thing more expensive than health insurance is perhaps the costs of insuring shares of health insurers. Case…
Read More...

The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines.Instead, drugmakers are…
Read More...

Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose of…
Read More...

The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersEvery time Novo urges investors to look ahead,…
Read More...

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
Read More...

Cardinal Health on Tuesday showed why the healthcare distributor belongs in our portfolio, delivering robust…
Read More...

Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to…
Read More...

CNBC's Jim Cramer said Monday that investors shouldn't fear the latest market rotation. Instead, he thinks it's…
Read More...

The U.S. Food and Drug Administration has approved Eli Lilly's GLP-1 pill, the company said, a major milestone for…
Read More...

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.Mike Blake |…
Read More...